141 related articles for article (PubMed ID: 20372806)
1. Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis.
Suzuki E; Daniels TR; Helguera G; Penichet ML; Umezawa K; Bonavida B
Int J Oncol; 2010 May; 36(5):1299-307. PubMed ID: 20372806
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief Communication.
Daniels-Wells TR; Widney DP; Leoh LS; Martínez-Maza O; Penichet ML
J Immunother; 2015 Oct; 38(8):307-10. PubMed ID: 26325374
[TBL] [Abstract][Full Text] [Related]
3. An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies.
Daniels TR; Ortiz-Sánchez E; Luria-Pérez R; Quintero R; Helguera G; Bonavida B; Martínez-Maza O; Penichet ML
J Immunother; 2011; 34(6):500-8. PubMed ID: 21654517
[TBL] [Abstract][Full Text] [Related]
4. Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.
Daniels-Wells TR; Helguera G; Rodríguez JA; Leoh LS; Erb MA; Diamante G; Casero D; Pellegrini M; Martínez-Maza O; Penichet ML
Toxicol In Vitro; 2013 Feb; 27(1):220-31. PubMed ID: 23085102
[TBL] [Abstract][Full Text] [Related]
5. Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter.
Leoh LS; Morizono K; Kershaw KM; Chen IS; Penichet ML; Daniels-Wells TR
J Gene Med; 2014; 16(1-2):11-27. PubMed ID: 24436117
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma.
Leoh LS; Kim YK; Candelaria PV; Martínez-Maza O; Daniels-Wells TR; Penichet ML
J Immunol; 2018 May; 200(10):3485-3494. PubMed ID: 29654211
[TBL] [Abstract][Full Text] [Related]
7. Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells.
Rodríguez JA; Luria-Pérez R; López-Valdés HE; Casero D; Daniels TR; Patel S; Avila D; Leuchter R; So S; Ortiz-Sánchez E; Bonavida B; Martínez-Maza O; Charles AC; Pellegrini M; Helguera G; Penichet ML
Leuk Lymphoma; 2011 Nov; 52(11):2169-78. PubMed ID: 21870996
[TBL] [Abstract][Full Text] [Related]
8. Alkaloids from Stephania venosa as Chemo-Sensitizers in SKOV3 Ovarian Cancer Cells via Akt/NF-κB Signaling.
Mon MT; Yodkeeree S; Punfa W; Pompimon W; Limtrakul P
Chem Pharm Bull (Tokyo); 2018; 66(2):162-169. PubMed ID: 29386467
[TBL] [Abstract][Full Text] [Related]
9. An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication.
Daniels-Wells TR; Candelaria PV; Leoh LS; Nava M; Martínez-Maza O; Penichet ML
J Immunother; 2020; 43(2):48-52. PubMed ID: 31693515
[TBL] [Abstract][Full Text] [Related]
10. Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV
Martínez LE; Daniels-Wells TR; Guo Y; Magpantay LI; Candelaria PV; Penichet ML; Martínez-Maza O; Epeldegui M
Mol Cancer Ther; 2021 Sep; 20(9):1592-1602. PubMed ID: 34158342
[TBL] [Abstract][Full Text] [Related]
11. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y
Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species.
Ortiz-Sánchez E; Daniels TR; Helguera G; Martinez-Maza O; Bonavida B; Penichet ML
Leukemia; 2009 Jan; 23(1):59-70. PubMed ID: 18946492
[TBL] [Abstract][Full Text] [Related]
13. DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway.
Fang Y; Chai Z; Wang D; Kuang T; Wu W; Lou W
Mol Cell Biochem; 2015 Jan; 399(1-2):269-78. PubMed ID: 25348361
[TBL] [Abstract][Full Text] [Related]
14. The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.
Baritaki S; Militello L; Malaponte G; Spandidos DA; Salcedo M; Bonavida B
Int J Oncol; 2011 Jun; 38(6):1683-94. PubMed ID: 21455568
[TBL] [Abstract][Full Text] [Related]
15. Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.
Ng PP; Helguera G; Daniels TR; Lomas SZ; Rodriguez JA; Schiller G; Bonavida B; Morrison SL; Penichet ML
Blood; 2006 Oct; 108(8):2745-54. PubMed ID: 16804109
[TBL] [Abstract][Full Text] [Related]
16. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway.
Yu M; Qi B; Xiaoxiang W; Xu J; Liu X
Biomed Pharmacother; 2017 Jun; 90():677-685. PubMed ID: 28415048
[TBL] [Abstract][Full Text] [Related]
17. Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells.
Daniels TR; Ng PP; Delgado T; Lynch MR; Schiller G; Helguera G; Penichet ML
Mol Cancer Ther; 2007 Nov; 6(11):2995-3008. PubMed ID: 18025284
[TBL] [Abstract][Full Text] [Related]
18. Anthocyanins Isolated from
Paramanantham A; Kim MJ; Jung EJ; Kim HJ; Chang SH; Jung JM; Hong SC; Shin SC; Kim GS; Lee WS
Molecules; 2020 Aug; 25(16):. PubMed ID: 32784919
[TBL] [Abstract][Full Text] [Related]
19. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
[TBL] [Abstract][Full Text] [Related]
20. An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells.
Ng PP; Dela Cruz JS; Sorour DN; Stinebaugh JM; Shin SU; Shin DS; Morrison SL; Penichet ML
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10706-11. PubMed ID: 12149472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
